Philip Reigan
- Molecular Biology top 5%
- Oncology top 5%
- Organic Chemistry top 5%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Donald S. BackosChristopher J. MathesonSteffanie L. FurtekDennis R. PetersenDavid RossDavid SiegelColin T. ShearnChristopher C. Franklin
- Topics
- Bioactive Compounds and Antitumor Agents (12 papers)Genomics, phytochemicals, and oxidative stress (11 papers)Cancer therapeutics and mechanisms (8 papers)
- Cited by
- ToxicologyMolecular BiologyOncology
- Journals
- Journal of Biological ChemistryJournal of NeuroscienceSHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Philip Reigan
75 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 2.0k
- Oncology 677
- Organic Chemistry 373
- Cancer Research 364
- Pathology and Forensic Medicine 280
Countries citing papers authored by Philip Reigan
This map shows the geographic impact of Philip Reigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Reigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Reigan more than expected).
Fields of papers citing papers by Philip Reigan
This network shows the impact of papers produced by Philip Reigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Reigan. The network helps show where Philip Reigan may publish in the future.
Co-authorship network of co-authors of Philip Reigan
This figure shows the co-authorship network connecting the top 25 collaborators of Philip Reigan. A scholar is included among the top collaborators of Philip Reigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Reigan. Philip Reigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 306 | |
| 9 | 56 | |
| 10 | 7 | |
| 11 | 106 | |
| 12 | 7 | |
| 13 | 54 | |
| 14 | 53 | |
| 15 | 76 | |
| 16 | 18 | |
| 17 | 15 | |
| 18 | 99 | |
| 19 | Molecular docking studies investigating the interaction of a series of benzoquinone ansamycin Hsp90 inhibitors with NAD(P)H:quinone oxidoreductase 1 (NQO1) | 1 |
| 20 | 18 |
About Philip Reigan
Philip Reigan is a scholar working on Toxicology, Molecular Biology and Biochemistry, having authored 78 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (12 papers), Genomics, phytochemicals, and oxidative stress (11 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Toxicology (209 citations), Molecular Biology (2.0k citations) and Oncology (677 citations). Philip Reigan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Donald S. Backos, Christopher J. Matheson, Steffanie L. Furtek, Dennis R. Petersen, David Ross, David Siegel, Colin T. Shearn, Christopher C. Franklin, Kristofer S. Fritz and Wenchang Guo. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.